Annual report pursuant to Section 13 and 15(d)

Subsequent Events (Details)

v3.24.1
Subsequent Events (Details) - Subsequent Event - USD ($)
$ / shares in Units, $ in Millions
Mar. 28, 2024
Mar. 25, 2024
Mar. 27, 2024
Private Placement      
Subsequent Event [Line Items]      
Net proceeds $ 185.0    
Proceeds from issuance of private placement 105.0    
Transaction costs $ 7.5    
Preferred Stock, convertible, shares issuable in common stock (in shares) 1,000    
Common stock, shares outstanding after private placement and preferred stock conversion 23,400,000    
Preferred Stock | Private Placement      
Subsequent Event [Line Items]      
Net proceeds $ 115.6    
Number of shares issued (in shares) 19,900    
Warrant | Private Placement      
Subsequent Event [Line Items]      
Net proceeds $ 69.4    
Number of shares issued (in shares) 12,000,000.0    
Exercise price per share (in dollars per share) $ 5.80    
AlmataBio Transaction      
Subsequent Event [Line Items]      
Equity issuable   $ 15.0  
Common stock shares issued (in shares)   200,000  
Non-voting convertible preferred stock shares issued (in shares)   2,400  
Cash payments to acquire assets   $ 7.5  
AlmataBio Transaction | Milestone One      
Subsequent Event [Line Items]      
Contingent consideration     $ 5.0
AlmataBio Transaction | Milestone Two      
Subsequent Event [Line Items]      
Contingent consideration     $ 15.0